The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells

TMPRSS2 is regulated by androgen receptor signalling in the prostate, however it is unclear if blocking this signalling is beneficial in the context of SARS-CoV-2 lung infection. Here the authors show that antiandrogen treatment downregulates TMPRSS2 in the lung and reduces viral entry and infection...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: D. A. Leach, A. Mohr, E. S. Giotis, E. Cil, A. M. Isac, L. L. Yates, W. S. Barclay, R. M. Zwacka, C. L. Bevan, G. N. Brooke
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/054d5eddfbac4f51bb25f10d584c7186
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:054d5eddfbac4f51bb25f10d584c7186
record_format dspace
spelling oai:doaj.org-article:054d5eddfbac4f51bb25f10d584c71862021-12-02T16:31:43ZThe antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells10.1038/s41467-021-24342-y2041-1723https://doaj.org/article/054d5eddfbac4f51bb25f10d584c71862021-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24342-yhttps://doaj.org/toc/2041-1723TMPRSS2 is regulated by androgen receptor signalling in the prostate, however it is unclear if blocking this signalling is beneficial in the context of SARS-CoV-2 lung infection. Here the authors show that antiandrogen treatment downregulates TMPRSS2 in the lung and reduces viral entry and infection.D. A. LeachA. MohrE. S. GiotisE. CilA. M. IsacL. L. YatesW. S. BarclayR. M. ZwackaC. L. BevanG. N. BrookeNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
D. A. Leach
A. Mohr
E. S. Giotis
E. Cil
A. M. Isac
L. L. Yates
W. S. Barclay
R. M. Zwacka
C. L. Bevan
G. N. Brooke
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
description TMPRSS2 is regulated by androgen receptor signalling in the prostate, however it is unclear if blocking this signalling is beneficial in the context of SARS-CoV-2 lung infection. Here the authors show that antiandrogen treatment downregulates TMPRSS2 in the lung and reduces viral entry and infection.
format article
author D. A. Leach
A. Mohr
E. S. Giotis
E. Cil
A. M. Isac
L. L. Yates
W. S. Barclay
R. M. Zwacka
C. L. Bevan
G. N. Brooke
author_facet D. A. Leach
A. Mohr
E. S. Giotis
E. Cil
A. M. Isac
L. L. Yates
W. S. Barclay
R. M. Zwacka
C. L. Bevan
G. N. Brooke
author_sort D. A. Leach
title The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
title_short The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
title_full The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
title_fullStr The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
title_full_unstemmed The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
title_sort antiandrogen enzalutamide downregulates tmprss2 and reduces cellular entry of sars-cov-2 in human lung cells
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/054d5eddfbac4f51bb25f10d584c7186
work_keys_str_mv AT daleach theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT amohr theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT esgiotis theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT ecil theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT amisac theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT llyates theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT wsbarclay theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT rmzwacka theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT clbevan theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT gnbrooke theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT daleach antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT amohr antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT esgiotis antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT ecil antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT amisac antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT llyates antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT wsbarclay antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT rmzwacka antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT clbevan antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
AT gnbrooke antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells
_version_ 1718383853144375296